The immunotherapeutic potential of melatonin

Expert Opinion on Investigational Drugs

Volumn 10, Issue 3, 2001, Pages 467-476

  Maestroni, G J M ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Cytokines; Haemopoiesis; Immunodeficiency; Melatonin; Rheumatoid arthritis; Septic shock; T helper; Viral encephalitis

Indexed keywords

CARBOPLATIN; CYTOKINE; ETOPOSIDE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; NEUROHORMONE; NITRIC OXIDE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; HEMATOPOIESIS; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PHOTOPERIODICITY; PRE B LYMPHOCYTE; RAT; REVIEW; RHEUMATOID ARTHRITIS; SEASONAL VARIATION; TH1 CELL; TH2 CELL; VIRUS INFECTION;

ANIMALS; ANTIOXIDANTS; HUMANS; IMMUNITY; IMMUNOTHERAPY; MELATONIN;

EID: 0035110719     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.10.3.467     Document Type: Review

References (70)

1. Neuroimmunomodulation: Neuroimmune interactions with the environment
2. Psychoneuroimmunology: Interactions between the nervous system and the immune system
3. Melatonin: History, biosynthesis and assay methodology
4. Isolation of melatonin, the pineal gland factor that lightens melanocytes
5. Reduced cancer incidence among the blind
6. Melatonin madness
7. Cellular mechanisms of melatonin action
8. Evidence for a direct action of melatonin on the immune system
9. T helper 2 lymphocytes as a peripheral target of melatonin
10. The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist(s) with immunoenhancing and anti-stress properties
11. Selective effect of methoxyndoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells
12. Melatonin enhances IL-2, IL-6 and IFN-γ production by human circulating CD4+ cells
13. Signal transduction for melatonin in human lymphocytes. Involvement of a pertussis toxin-sensitive G protein
14. Mechanisms of action on the human immune system: Membrane receptors versus nuclear receptors
15. Differential expression of the melatonin receptor in human monocytes
16. Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat
17. Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production in human blood mononuclear cells
18. The photoperiod transducer melatonin and the immune-hematopoietic system
19. Melatonin administration attenuates depressed immune functions after trauma-hemorrhage
20. Role of photoperiod and the pineal gland in T cell-dependent humoral immune reactivity in the Siberian hamster
21. Effects of photoperiod and melatonin on lymphocyte activities in male broiler chickens
22. Effects of lighting conditions and melatonin supplementation of the cellular and humoral immune responses in Japanese quail Coturnix coturnix japonica
23. Diurnal rhythmicity of human cytokine production. A dynamic disequilibrium in T helper cell type1/T helper cell Type 2 balance
24. Disruption of nocturnal melatonin rhythm and immunological involvement in ischaemic stroke patients
25. Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin α1 and thymulin concentrations: Observations in rats and humans
26. Regulation of interleukin-2/interleukin-12 interactions by the pineal gland
27. Melatonin activates Th1 lymphocytes by increasing IL-12 production
28. The effect of melatonin on cellular activation processes in human blood
29. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines
30. Endocrinology meets immunology: T lymphocytes as novel targets for melatonin
31. Hematopoietic rescue via T-cell-dependent, endogenous GM-CSF by the pineal neurohormone melatonin in tumor bearing mice
32. Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4
33. Hematopoietic effect of melatonin. Involvement of k1-opioid receptor on bone marrow macrophages and interleukin-1
34. Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin
35. Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs
36. Melatonin decreases bone marrow and lymphatic toxicity of adryamycin in mice bearing TLX5 lymphoma
37. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as first-line treatment of advanced non-small cell lung cancer poor clinical state
38. Double blind randomized study on the myeloprotective effect of melatonin given in combination with carboplatin and etoposide in advanced lung cancer
39. Cis-platinum-induced immunosuppression: Relationship with melatonin in human peripheral blood mononuclear cells
40. Exogenous melatonin: Qualitative enhancement in vivo of cells mediating non-specific immunity
41. Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow
42. Melatonin restores and enhances the human type B tonsillar lymphocyte subset in recurrent acute tonsillitis
43. Melatonin in palate tonsils with recurrent acute tonsillitis and tonsillar hyperthrophy
44. Melatonin in relation to the antioxidative defense and immune systems: Possible implications for cell and organ transplantation
45. West Nile encephalitis epidemic in southeastern Romania
46. Protective effect of melatonin in viral and bacterial infections
47. Protective effect of melatonin in mice infected with encephalitis viruses
48. Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus
49. Pathophysiology of septic shock and implications for therapy
50. Interleukin-1β and tumor necrosis factor-a synergistically induce NO synthase in rat vascular smooth muscle cells
51. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: Role of TNF-α and IL-1β
52. Synthesis of nitric oxide from a terminal guanidino atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron
53. Inhibition of nitric oxide synthase in experimental Gram-negative sepsis
54. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice
55. Melatonin as a therapeutic agent in experimental endotoxic shock
56. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NFkappB activation
57. Dehydroiepiandrosterone and melatonin prevent Bacillus anthracis lethal toxin-induced TNF production in macrophages
58. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice
59. Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells
60. Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis
61. Daylight length does not affect experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis (MS)
62. Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge
63. Interleukin-12: A new player in cytokine therapy
64. Cancer vaccines
65. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment
66. Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin specific T cells
67. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease
68. Evidence for melatonin synthesis in mouse and human bone marrow cells
69. Identification of higher elevated levels of melatonin in bone marrow: Its origin and significance